ANXA1 and cancer: In contrast, the proteins: MARE1, ANXA1, RSSA, ACTB, CALU, CH60 and HSP7C that were restored due to treatment with both synergistic and antagonistic combinations, may not be so critically associated with synergistic drug action in spite of them being a hallmark of cancer cell biology and platinum drug resistance.